CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 41  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0649
LYS 10.0549
GLU 20.0244
LEU 30.0185
ARG 40.0191
CYS 50.0116
GLN 60.0118
CYS 70.0262
ILE 80.0521
LYS 90.0509
THR 100.0287
TYR 110.0247
SER 120.0377
LYS 130.0494
PRO 140.0330
PHE 150.0202
HIS 160.0070
PRO 170.0040
LYS 180.0050
PHE 190.0101
ILE 200.0097
LYS 210.0203
GLU 220.0190
LEU 230.0142
ARG 240.0170
VAL 250.0152
ILE 260.0209
GLU 270.0049
SER 280.0109
GLY 290.0130
PRO 300.0649
HIS 310.0191
CYS 320.0045
ALA 330.0220
ASN 340.0186
THR 350.0210
GLU 360.0171
ILE 370.0076
ILE 380.0110
VAL 390.0114
LYS 400.0186
LEU 410.0226
SER 420.0218
ASP 430.0418
GLY 440.0253
ARG 450.0246
GLU 460.0201
LEU 470.0133
CYS 480.0112
LEU 490.0101
ASP 500.0167
PRO 510.0228
LYS 520.0271
GLU 530.0113
ASN 540.0256
TRP 550.0167
VAL 560.0221
GLN 570.0288
ARG 580.0211
VAL 590.0150
VAL 600.0121
GLU 610.0197
LYS 620.0161
PHE 630.0081
LEU 640.0152
LYS 650.0176
ARG 660.0182
ALA 670.0151
GLU 680.0175
ASN 690.0511

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.